BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
37 results:

  • 1. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
    Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
    [No Abstract]    [Full Text] [Related]  

  • 2. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
    Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
    Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in gastric cancer.
    Ye H; Shi W; Yang J; Wang L; Jiang X; Zhao H; Qin L; Qin J; Li L; Cai W; Guan J; Yang H; Zhou H; Yu Z; Sun H; Jiao Z
    Cancer Res; 2023 Nov; 83(22):3767-3782. PubMed ID: 37646571
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of SMARCA2 and smarca4 in gastric adenocarcinoma and construction of a nomogram prognostic model.
    Zhang Z; Li Q; Sun S; Li Z; Cui Z; Liu Q; Zhang Y; Xiong S; Zhang S
    Int J Clin Oncol; 2023 Nov; 28(11):1487-1500. PubMed ID: 37634210
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinicopathological characteristics of gastric smarca4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 6. smarca4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
    Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
    Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. smarca4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplification.
    Pries K; Krüger S; Heckl S; Behrens HM; Röcken C
    Cancer Med; 2023 May; 12(9):10423-10437. PubMed ID: 36916408
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Switch/Sucrose Non-Fermentable Complex-Deficient Rhabdoid Carcinoma of Stomach: A Rare Case Report and Literature Review.
    Chen M; Yao X; Ping J; Shen H; Wei Y; Wang WL
    Int J Surg Pathol; 2023 Oct; 31(7):1364-1374. PubMed ID: 36895105
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
    Yin YX; Ling YH; Wei XL; He CY; Wang BZ; Hu CF; Lin WP; Nie RC; Chen JW; Lin JL; Zhou J; Xie JJ; Yun JP; Xie D; Xue LY; Cai MY
    Front Immunol; 2022; 13():973085. PubMed ID: 36591236
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and Treatment of smarca4 Deficient Poorly Differentiated gastric Carcinoma.
    Bhat V; Koneru M; Knapp K; Joneja U; Morrison J; Hong YK
    Am Surg; 2023 Nov; 89(11):4987-4989. PubMed ID: 36533880
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
    Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
    [No Abstract]    [Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
    Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
    World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in gastric cancer.
    Nargund AM; Xu C; Mandoli A; Okabe A; Chen GB; Huang KK; Sheng T; Yao X; Teo JMN; Sundar R; Kok YJ; See YX; Xing M; Li Z; Yong CH; Anand A; A I ZF; Poon LF; Ng MSW; Koh JYP; Ooi WF; Tay ST; Ong X; Tan ALK; Grabsch HI; Fullwood MJ; Teh TB; Bi X; Kaneda A; Li S; Tan P
    Cancer Res; 2022 Jul; 82(14):2538-2551. PubMed ID: 35583999
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The first case of smarca4-deficient sarcoma of stomach.
    Ota T; Ishikawa T; Yasuda R; Yasuda T; Okayama T; Inoue K; Dohi O; Yoshida N; Kamada K; Uchiyama K; Takagi T; Konishi H; Naito Y; Matsuyama K; Yamaguchi T; Ootsuka K; Yoshida A; Kishimoto M; Itoh Y
    Clin J Gastroenterol; 2022 Jun; 15(3):531-536. PubMed ID: 35175571
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor progression by epithelial-mesenchymal transition in ARID1A- and smarca4-aberrant solid-type poorly differentiated gastric adenocarcinoma.
    Sasaki T; Kohashi K; Kawatoko S; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y
    Virchows Arch; 2022 May; 480(5):1063-1075. PubMed ID: 34997313
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [gastric SWI/SNF-complex deficient undifferentiated/rhabdoid carcinoma: a clinicopathological study].
    Wang L; Tan C; Ni SJ; Jiang WH; Xu J; Cai X; Huang D; Sheng WQ; Chang B
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):632-637. PubMed ID: 34078052
    [No Abstract]    [Full Text] [Related]  

  • 18. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
    Huang SC; Ng KF; Chang IY; Chang CJ; Chao YC; Chang SC; Chen MC; Yeh TS; Chen TC
    PLoS One; 2021; 16(1):e0245356. PubMed ID: 33481850
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. smarca4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.
    Horton RK; Ahadi M; Gill AJ; Said S; Chen ZE; Bakhshwin A; Nichols M; Goldblum JR; Graham RP
    Am J Surg Pathol; 2021 Mar; 45(3):414-420. PubMed ID: 33027072
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.